Similar Search Results

Patent purchase as a policy for pharmaceuticals

Hout, Ben van; McHardy, Jolian P.; Tsuchiya, Aki - 2015

Persistent link: https://www.econbiz.de/10011282783

Decoding the adaptability-rigidity puzzle : evidence from pharmaceutical incumbents’ pursuit of gene therapy and monoclonal antibodies

Kapoor, Rahul; Klueter, Thomas - In: Academy of Management journal : AMJ 58 (2015) 4, pp. 1180-1207

Persistent link: https://www.econbiz.de/10011349517

A regulatory clinical trial primer : distribution challenges and policy implications of modern vaccine development

Fiedler, Beth Ann; Bebber, Robert J.; Oetjen, Reid M. - In: International journal of pharmaceutical and healthcare … 7 (2013) 1, pp. 45-57

Persistent link: https://www.econbiz.de/10009752651

Collaboration and innovation in the pharmaceutical industry

Rake, Bastian - 2012

Persistent link: https://www.econbiz.de/10009696589

Contract research organizations : an industry analysis

Masri, Maysoun Dimachkie; Ramirez, Bernardo; Popescu, … - In: International journal of pharmaceutical and healthcare … 6 (2012) 4, pp. 336-350

Persistent link: https://www.econbiz.de/10009699701

Portfolio management in new drug development

Ding, Min; Dong, Songting; Eliashberg, Jehoshua; … - In: Innovation and marketing in the pharmaceutical industry …, (pp. 83-118). 2014

Persistent link: https://www.econbiz.de/10010353582

IPRs, public health and the pharmaceutical industry : issues in the post-2005 TRIPS agenda

Coriat, Benjamin; Orsenigo, Luigi - In: Intellectual property rights : legal and economic …, (pp. 219-241). 2014

Persistent link: https://www.econbiz.de/10010354866

Managing integrated development in the pharmaceutical industry : a cross-functional approach to development of more efficient manufacturing processes

Ziegler, Reto Marc - 2014

Aktuelle Zahlen aus der pharmazeutischen Industrie zeigen, dass die Entwicklung von neuen Produkten immer länger dauert und immer mehr kostet. Zudem schaffen immer weniger Produkte die Hürde der klinischen Entwicklung. Man spricht schon fast von einem Produktivitätsproblem der Forschung und...

Persistent link: https://www.econbiz.de/10010256239

The empirical application of real options and corporate competencies to research and development in the pharmaceutical industry

Marchiodi, Ombretta - 2014

Persistent link: https://www.econbiz.de/10011437318

Private versus social incentives for pharmaceutical innovation

González, Paula; Macho-Stadler, Inés; … - 2015

Persistent link: https://www.econbiz.de/10011458544